Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 10:00:04 pm
46.01 USD   -2.75%
2014Amid Alibaba fever, reasons for caution in IPO market
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Latest news on ULTRAGENYX PHARMACEUTICAL
12/07Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita (buros..
AQ
12/06Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™..
GL
11/15ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
11/14ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
11/14ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
11/12ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
11/09ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
11/06ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
11/05ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
11/05ULTRAGENYX : 3Q Earnings Snapshot
AQ
11/05Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update
GL
11/01Lilly buys Siga's Priority Review voucher gained via smallpox approval
AQ
10/30Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results a..
GL
10/29ULTRAGENYX PHARMACEUTICAL : Announces Negative Topline Results from Phase 3 Stud..
AQ
10/29ULTRAGENYX PHARMACEUTICAL : UX007 fails Phase III in glucose transporter disorde..
AQ
10/26Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in ..
GL
10/23ULTRAGENYX PHARMACEUTICAL : Announces Exclusive License to REGENXBIO AAV Vectors..
AQ
10/23ULTRAGENYX PHARMACEUTICAL : Announces Exclusive License to REGENXBIO AAV Vectors..
AQ
10/22Ultragenyx Announces Exclusive License to REGENXBIO AAV Vectors to Develop Ge..
GL
10/19ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Brazil for the Tre..
AQ
10/18Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazi..
GL
10/09FDA, EMA to review Novartis' siponimod for secondary progressive MS
AQ
10/01ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
09/27ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
09/27Ultragenyx Announces Positive Topline Cohort 2 Results from Phase 1/2 Clinica..
GL
09/26ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
09/19ULTRAGENYX PHARMACEUTICAL : Expands Leadership Team and Appoints Dr. Wladimir Ho..
AQ
09/19ULTRAGENYX PHARMACEUTICAL : appoints Dr. Wladimir Hogenhuis as COO
AQ
09/17ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers, Fina..
AQ
09/17Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chi..
GL
08/30Ultragenyx to Present at Upcoming Investor Conferences
GL
08/30ULTRAGENYX PHARMACEUTICAL : FDA clarifies path to submission for Ultragenyx's ra..
AQ
08/29ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
08/29ULTRAGENYX PHARMACEUTICAL : Announces FDA Accepts Proposal to Submit an NDA for ..
AQ
08/28ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Europe for the Tre..
AQ
08/28ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii (vestronidase alfa) i..
AQ
08/27Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europ..
GL
08/22ULTRAGENYX PHARMACEUTICAL INC. : Temporary Suspension of Trading Under Registran..
AQ
08/03ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
08/03ULTRAGENYX PHARMACEUTICAL INC. : Regulation FD Disclosure, Financial Statements ..
AQ
08/03ULTRAGENYX : 2Q Earnings Snapshot
AQ
08/02ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
08/02Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
GL
07/31ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Second Quarter 2018 Fina..
AQ
07/31ULTRAGENYX PHARMACEUTICAL : doses first patient in DTX401 Phase 1/2 study to tre..
AQ
07/27ULTRAGENYX PHARMACEUTICAL : Announces First Patient Dosed in Phase 1/2 study of ..
AQ
07/27Ultragenyx to Host Conference Call for Second Quarter 2018 Financial Results ..
GL
07/26ULTRAGENYX PHARMACEUTICAL : Announces First Patient Dosed in Phase 1/2 study of ..
AQ
07/04ULTRAGENYX PHARMACEUTICAL : Announces Positive CHMP Opinion for Mepsevii for the..
AQ
07/02CHMP backs CAR Ts, Orphan candidates
AQ
06/29Ultragenyx Announces Positive CHMP Opinion for Mepsevii™ (vestronidase ..
GL
06/21ULTRAGENYX PHARMACEUTICAL INC. : Submission of Matters to a Vote of Security Hol..
AQ
06/08ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers (form..
AQ
06/04ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
05/24Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
AQ
05/24Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
AQ
05/23Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
GL
05/22Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results
AQ
05/21Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrati..
AQ
05/18Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrati..
AQ
05/17Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrati..
GL
05/11Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the..
AQ
05/11ULTRAGENYX PHARMACEUTICAL : Reports First Quarter 2018 Financial Results and Cor..
AQ
05/08ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
05/07ULTRAGENYX : 1Q Earnings Snapshot
AQ
05/07ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
05/07Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update
GL
05/04ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for First Quarter 2018 Finan..
AQ
05/03Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the..
AQ
05/01Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results a..
GL
04/30Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched i..
GL
04/23Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug ..
GL
04/17ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
04/17Ultragenyx and Kyowa Kirin Announce FDA Approval of Crysvita® (burosumab-twza..
GL
03/30ULTRAGENYX PHARMACEUTICAL INC. : Entry into a Material Definitive Agreement, Fin..
AQ
1  2  3  4Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL